Correlation Between Gentex and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both Gentex and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gentex and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gentex and bioAffinity Technologies,, you can compare the effects of market volatilities on Gentex and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gentex with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gentex and BioAffinity Technologies,.
Diversification Opportunities for Gentex and BioAffinity Technologies,
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gentex and BioAffinity is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Gentex and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Gentex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gentex are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Gentex i.e., Gentex and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between Gentex and BioAffinity Technologies,
Given the investment horizon of 90 days Gentex is expected to generate 0.12 times more return on investment than BioAffinity Technologies,. However, Gentex is 8.15 times less risky than BioAffinity Technologies,. It trades about 0.1 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about -0.01 per unit of risk. If you would invest 2,106 in Gentex on April 15, 2025 and sell it today you would earn a total of 196.00 from holding Gentex or generate 9.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gentex vs. bioAffinity Technologies,
Performance |
| Timeline |
| Gentex |
| bioAffinity Technologies, |
Gentex and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gentex and BioAffinity Technologies,
The main advantage of trading using opposite Gentex and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gentex position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.The idea behind Gentex and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| BioAffinity Technologies, vs. Addentax Group Corp | BioAffinity Technologies, vs. Shuttle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |